Glow-in-the-dark dye helps surgeons spot hidden pancreatic cancer

NCT ID NCT03384238

Recruiting now Diagnosis Sponsor: George Poultsides Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a dye called panitumumab-IRDye800 that attaches to pancreatic cancer cells and makes them glow under a special camera during surgery. The goal is to help surgeons see and remove all cancer tissue, including tiny spots that might otherwise be missed. About 27 adults with pancreatic cancer who are scheduled for surgery will take part. The study checks for side effects and how well the dye works at finding cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC ADENOCARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Stanford University, School of Medicine
RECRUITING

Palo Alto, California, 94304, United States

Contact Email: •••••@•••••

Contact